Impact of MHC class I diversity on immune control of immunodeficiency virus replication.
The recent failure of the T-cell-based HIV vaccine trial led by Merck and Co., Inc. prompts the urgent need to refocus on the question of which T-cell responses are required to control HIV replication. The well-described association between the expression of particular MHC class I molecules and succ...
| Principais autores: | , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
2008
|